BlueWind Medical Ltd. announced that it has received $64 million in its series B funding round on May 9, 2022. The transaction was led by new investor ConvaTec Group Plc, which invested $30 million along with other investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
256.8 GBX | -0.77% | +3.29% | +5.75% |
May. 03 | Deutsche Bank Begins Convatec Group Coverage with Buy Rating | MT |
May. 03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.75% | 6.66B | |
-4.02% | 184B | |
-0.75% | 109B | |
-2.97% | 68.37B | |
+4.48% | 51.56B | |
+9.09% | 44.69B | |
+4.37% | 41.49B | |
+3.12% | 26.75B | |
+4.10% | 26.7B | |
+15.38% | 25.68B |
- Stock Market
- Equities
- CTEC Stock
- News ConvaTec Group Plc
- BlueWind Medical Ltd. announced that it has received $64 million in funding from ConvaTec Group Plc